Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00744640
What this trial is testing

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
University Hospital, Basel, Switzerland 46
Early research (Phase 1)Study completedNCT01473940
What this trial is testing

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
Northwestern University 21
Not applicableStudy completedNCT03105921
What this trial is testing

Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaInterventional Imaging
Poitiers University Hospital 20
Early research (Phase 1)Ended earlyNCT00121745
What this trial is testing

Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Epeius Biotechnologies 12
Early research (Phase 1)Study completedNCT01893294
What this trial is testing

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer
Mayo Clinic 1
Early research (Phase 1)Looking for participantsNCT04678648
What this trial is testing

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmRAS MutationLung Cancer+3 more
RasCal Therapeutics, Inc. 134
Testing effectiveness (Phase 2)Study completedNCT00026104
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage II Pancreatic CancerStage III Pancreatic Cancer
National Cancer Institute (NCI) 154
Testing effectiveness (Phase 2)Active Not RecruitingNCT04390399
What this trial is testing

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
ImmunityBio, Inc. 328
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Testing effectiveness (Phase 2)Study completedNCT00303927
What this trial is testing

Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 65
Testing effectiveness (Phase 2)Looking for participantsNCT07483554
What this trial is testing

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

Who this might be right for
CLDN18.2 PositiveGastric/Gastroesophageal Junction AdenocarcinomaPancreatic Ductal Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd. 389
Testing effectiveness (Phase 2)Ended earlyNCT00307723
What this trial is testing

Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Massachusetts General Hospital 52
Large-scale testing (Phase 3)Study completedNCT00417209
What this trial is testing

Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen

Who this might be right for
Pancreatic Neoplasms
Sanofi 408
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableStudy completedNCT02791503
What this trial is testing

CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy

Who this might be right for
Pancreatic Neoplasm
Dr. M.R. Meijerink 74
Testing effectiveness (Phase 2)Looking for participantsNCT04657068
What this trial is testing

ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerOvarian Cancer+6 more
Artios Pharma Ltd 542
Not applicableLooking for participantsNCT06755359
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic Cancer
Alpha Tau Medical LTD. 40
Large-scale testing (Phase 3)WithdrawnNCT03536182
What this trial is testing

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT00019435
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04581876
What this trial is testing

The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Fudan University 120
Next Page